Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia
Authors:
Open Access
- 3 May 2010
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 46 (2) , 310-311
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Voriconazole Pharmacokinetics and Pharmacodynamics in ChildrenClinical Infectious Diseases, 2010
- Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric StudiesAntimicrobial Agents and Chemotherapy, 2009
- Hematopoietic SCT in patients with a history of invasive fungal infectionBone Marrow Transplantation, 2008
- Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipientsJournal of Antimicrobial Chemotherapy, 2008
- Fatal Disseminated Trichosporon asahii Infection in a Child with Acute Lymphoblastic LeukemiaCanadian Journal of Infectious Diseases and Medical Microbiology, 2007
- Successful Treatment of Breakthrough Trichosporon asahii Fungemia with Voriconazole in a Patient with Acute Myeloid LeukemiaClinical Infectious Diseases, 2006
- Fungemia due to Trichosporon asahii in a Neutropenic Child Refractory to Amphotericin BJournal of Pediatric Hematology/Oncology, 2005
- Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipientsBone Marrow Transplantation, 2004
- Use of Voriconazole to Successfully Treat Disseminated Trichosporon asahii Infection in a Patient with Acute Myeloid LeukaemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Trichosporon beigelii: a life-threatening pathogen in immunocompromised hostsBone Marrow Transplantation, 2000